Jyothy Labs Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Household Products | Market Cap: ₹7.5K Cr
Jyothy Labs aims for double-digit revenue growth in FY27, excluding Pril and FA brands. Management expects double-digit revenue growth for FY27, excluding Pril and FA businesses.
From Jyothy Labs's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹213
Market Cap
₹7.5K Cr
P/E Ratio
26.5
Revenue Rank
Margin Rank
How does Jyothy Labs rank in Household Products?
Compare Jyothy Labs against every Household Products company this quarter on revenue, margins and earnings-call signals.
Jyothy Labs — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹717 Cr, net profit ₹68 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →Jyothy Labs aims for double-digit revenue growth in FY27, excluding Pril and FA brands.
- →Growth across all segments expected: Fabric Care, Home Care, and Personal Care.
- →Fabric Care continues strong with over 14% value and 10% volume growth in Q1.
- →Personal Care showed subdued performance in Q1 but expected to recover and perform strongly from Q2 onwards.
- →Dishwash segment expected to scale up, with new Exo liquid launched recently showing reasonable growth.
- →High single-digit volume growth is targeted throughout the year.
- →Modern trade, e-commerce, and quick commerce are fast-growing channels and expected to maintain strong momentum.
- →Management confident volume growth will complement pricing actions to sustain growth.
- →Overall, all three segments expected to perform reasonably well, supporting optimistic growth outlook.
📈 Profitability & Margins
Rank 2- →Management expects double-digit revenue growth for FY27, excluding Pril and FA businesses.
- →EBITDA margins likely to remain under pressure in FY27 due to high crude-linked input costs.
- →Margin recovery is anticipated to be gradual and linked to commodity price stability and top-line growth.
- →Second half of FY27 expected to deliver better growth and profitability compared to the first half, subject to demand and commodity prices.
- →Focus on cost optimization, supply chain efficiencies, procurement excellence, value engineering, and selective pricing to restore profitability.
- →Operating leverage and volume growth expected to support margin recovery over coming quarters.
- →Management aims to return to historical margin levels over the medium term, depending on crude price trends.
- →New product launches, premiumization, and expansion into new categories planned to drive long-term growth.
- →Confidence expressed in achieving steady-state EBITDA margins closer to 18-20% in 2-3 years, supported by pricing power and improved competitiveness.
🏗️ Capital Expenditure Plans
Yes- →The company is actively investing in innovation and product development as part of ongoing cost-saving initiatives.
- →Focus on scaling recent new product developments (NPDs) and maintaining a strong innovation pipeline.
- →Investments are calibrated and aimed at supporting sustainable long-term growth, including stepping up advertising and brand building.
- →No specific large capex projects or amounts disclosed in the transcript.
- →Management is evaluating M&A opportunities aligned with the company’s growth strategy but is selective and not pursuing acquisitions for the sake of it.
- →No immediate M&A deals finalized; past evaluation of TTK brands was rejected due to strategic misalignment and overlap.
- →Overall, capital investments appear focused on innovation, product launches, and possibly smaller strategic acquisitions, aligning with growth and margin recovery goals.
💰 Fundraising & Capital Structure
No information- →The transcript does not mention any current or planned fundraising through debt or equity.
- →Management emphasized disciplined capital allocation and focus on cost optimization.
- →They continue to look for acquisition opportunities but only if aligned with the company’s growth strategy; no specific deals or fundraises were disclosed.
- →No discussion of issuing new equity or debt was made during the Q&A or opening remarks.
- →The company has a net cash balance of about INR 850 crores, indicating no immediate need for external fundraising.
- →Overall, no indications of near-term debt or equity fundraisings were provided in this call.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Jyothy Labs's management said in earlier quarters
Others in Household Products this season
- Navneet Educat. (Q1 FY27)
45-50 crore additional in Q2 vs Q1). Key concall takeaways from Navneet Educat.'s Q1 FY27 earnings call — and how it ranks against sector peers.
- Flair Writing (Q1 FY27)
Q1 FY27 Capex: INR 43.42 crores total . Key concall takeaways from Flair Writing's Q1 FY27 earnings call — and how it ranks against sector peers.
- Eveready Inds. (Q1 FY27)
Alkaline battery segment growing at ~20% CAGR, driving overall battery market growth. Key concall takeaways from Eveready Inds.'s Q1 FY27 earnings call — and…
- Linc (Q1 FY27)
Sales growth was mixed in Q1 FY '27: corporate sales declined 14%, exports down 3%, but general trade grew 8% and e-commerce surged 32%. Key concall takeaways…
Frequently Asked Questions
What were Jyothy Labs Q1 FY27 results?
Jyothy Labs aims for double-digit revenue growth in FY27, excluding Pril and FA brands. Management expects double-digit revenue growth for FY27, excluding Pril and FA businesses.
What is Jyothy Labs share price analysis?
Jyothy Labs currently shows a below-average growth signal. The stock trades at a P/E of 26.5 with a market cap of ₹7,526 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jyothy Labs planning capital expenditure?
The company is actively investing in innovation and product development as part of ongoing cost-saving initiatives.
Keep Jyothy Labs on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.